NCT04930289Enrolling by invitation
Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs
Source: ClinicalTrials.gov · Last updated 18 Sept 2026
Brief summary (registry, in English)
The objective of this registry is to collect and evaluate various clinical effectiveness parameters in patients with transplanted donor lung that were preserved and transported within the LUNGguard system, as well as retrospective standard of care patients
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 3500 (estimated)
- First submitted
- 9 Jun 2021
- Start date
- 15 Oct 2021
- Primary completion date
- 15 Jun 2028
- Lead sponsor
- Paragonix Technologies
- NCT number
- NCT04930289
What you commit to
- Study type: Observational
- Planned participants: 3500
- From 15 Oct 2021 to the primary completion date, 15 Jun 2028
- 15 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Donor and donor lungs that do not meet institutional clinical requirements for transplantation
- Patients who have had a previous major organ transplant (heart, lungs, liver, kidney, pancreas)
- Patients who are receiving multiple organ transplants
Other
- Patients who are incarcerated persons (prisoners)
Who the study is looking for
- Donor and donor lungs matched to the prospective recipient based upon institutional medical practice
- Registered male or female primary lung transplant candidates including pediatric candidates
Sex: All · Does not accept healthy volunteers
Sites (15)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospitals Leuven Coordinator of this site? Confirm its status | Leuven | Belgium | Unknown status |
| Johns Hopkins University Coordinator of this site? Confirm its status | Baltimore | United States | Unknown status |
| Massachusetts General Hospital Coordinator of this site? Confirm its status | Boston | United States | Unknown status |
| University of Virginia Coordinator of this site? Confirm its status | Charlottesville | United States | Unknown status |
| The University of Texas Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
| Baylor Scott & White Research Institute Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
| Duke Lung Transplant Clinic Coordinator of this site? Confirm its status | Durham | United States | Unknown status |
| Houston Methodist Hospital Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
| Mayo Clinic- Jacksonville Coordinator of this site? Confirm its status | Jacksonville | United States | Unknown status |
| Temple University Hospital Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
| St. Joseph's Hospital and Medical Center Coordinator of this site? Confirm its status | Phoenix | United States | Unknown status |
| University of Pittsburgh Medical Center Coordinator of this site? Confirm its status | Pittsburgh | United States | Unknown status |
| University of California San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
| Stanford Medicine Coordinator of this site? Confirm its status | Stanford | United States | Unknown status |
| Montefiore Hospital Coordinator of this site? Confirm its status | The Bronx | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.